Overview

Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

Status:
Completed
Trial end date:
2003-04-30
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to assess the safety of long-term growth hormone treatment in growth-retarded children with intrauterine growth retardation (IUGR) enrolled in trial GHRETARD/F/1/F.
Phase:
Phase 4
Details
Lead Sponsor:
Novo Nordisk A/S